English

Concomitant Medications Open-Label Extension Assessing Long-Term Safety Of Rosiglitazone In Subjects With Mild To Moderate Alzheimer's Disease NCT00381238

1 forms  
Concomitant Medications
Description

Concomitant Medications

Alias
UMLS CUI-1
C2347852
Were any concomitant medications taken by the subject prior to screening and/or during the study? If yes, record each medication on a separate line using Trade Names where possible.
Description

Concomitant Medication

Data type

boolean

Alias
UMLS CUI [1]
C2347852
Medication
Description

Medication

Alias
UMLS CUI-1
C0013227
Drug name (Trade Name preferred) e.g. Aspirin
Description

Drug name

Data type

text

Alias
UMLS CUI [1]
C0013227
Unit Dose e.g. 200
Description

Unit Dose

Data type

float

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0869039
Units* (eg. mg)
Description

Units

Data type

text

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C1519795
Frequency* (e.g. BID)
Description

Frequency

Data type

text

Alias
UMLS CUI [1]
C3476109
Route* (e.g. PO)
Description

Route

Data type

text

Alias
UMLS CUI [1]
C0013153
Reason for Medication (e.g. Headache)
Description

Reason for Medication

Data type

text

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0392360
Start Date (e.g. 31 May 03)
Description

Start Date

Data type

date

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0808070
Stop Date (e.g. 31 May 03)
Description

Stop Date

Data type

date

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0806020
Ongoing Medication? (e.g. N)
Description

Ongoing Medication

Data type

boolean

Alias
UMLS CUI [1]
C2826666
Back to the top of the page

Similar models

Concomitant Medications Open-Label Extension Assessing Long-Term Safety Of Rosiglitazone In Subjects With Mild To Moderate Alzheimer's Disease NCT00381238

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Concomitant Medications
C2347852 (UMLS CUI-1)
Concomitant Medication
Item
Were any concomitant medications taken by the subject prior to screening and/or during the study? If yes, record each medication on a separate line using Trade Names where possible.
boolean
C2347852 (UMLS CUI [1])
Item Group
Medication
C0013227 (UMLS CUI-1)
Drug name
Item
Drug name (Trade Name preferred) e.g. Aspirin
text
C0013227 (UMLS CUI [1])
Unit Dose
Item
Unit Dose e.g. 200
float
C0013227 (UMLS CUI [1,1])
C0869039 (UMLS CUI [1,2])
Units
Item
Units* (eg. mg)
text
C0013227 (UMLS CUI [1,1])
C1519795 (UMLS CUI [1,2])
Frequency
Item
Frequency* (e.g. BID)
text
C3476109 (UMLS CUI [1])
Route
Item
Route* (e.g. PO)
text
C0013153 (UMLS CUI [1])
Reason for Medication
Item
Reason for Medication (e.g. Headache)
text
C0013227 (UMLS CUI [1,1])
C0392360 (UMLS CUI [1,2])
Start Date
Item
Start Date (e.g. 31 May 03)
date
C0013227 (UMLS CUI [1,1])
C0808070 (UMLS CUI [1,2])
Stop Date
Item
Stop Date (e.g. 31 May 03)
date
C0013227 (UMLS CUI [1,1])
C0806020 (UMLS CUI [1,2])
Ongoing Medication
Item
Ongoing Medication? (e.g. N)
boolean
C2826666 (UMLS CUI [1])
Back to the top of the page